PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34017375-0	2021	Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.	Cisplatin	100-109	kinesin family member 2A	Homo sapiens	0-24	
34017375-0	2021	Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.	Cisplatin	100-109	vascular endothelial growth factor A	Homo sapiens	137-141	
34017375-8	2021	KIF2A overexpression elevated proliferation, migration, invasion, stemness, and resistance to cisplatin but did not affect apoptosis or resistance to pemetrexed in A549 cells.	Cisplatin	94-103	kinesin family member 2A	Homo sapiens	0-5	
34017375-9	2021	Furthermore, KIF2A knock-down repressed proliferation, migration, invasion, stemness, and resistance to cisplatin, but not to pemetrexed, and it enhanced apoptosis in NCI-H1299 cells.	Cisplatin	104-113	kinesin family member 2A	Homo sapiens	13-18	
34017375-10	2021	Rescue experiments showed that the PI3K/AKT/VEGF pathway compensated for KIF2A effects on cell functions and sensitivity to cisplatin in A549 and NCI-H1299 cells.	Cisplatin	124-133	AKT serine/threonine kinase 1	Homo sapiens	40-43	
34017375-10	2021	Rescue experiments showed that the PI3K/AKT/VEGF pathway compensated for KIF2A effects on cell functions and sensitivity to cisplatin in A549 and NCI-H1299 cells.	Cisplatin	124-133	vascular endothelial growth factor A	Homo sapiens	44-48	
34017375-10	2021	Rescue experiments showed that the PI3K/AKT/VEGF pathway compensated for KIF2A effects on cell functions and sensitivity to cisplatin in A549 and NCI-H1299 cells.	Cisplatin	124-133	kinesin family member 2A	Homo sapiens	73-78	
34017375-11	2021	In conclusion, KIF2A advocates NSCLC cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway.	Cisplatin	96-105	kinesin family member 2A	Homo sapiens	15-20